NewGenIvf Group Limited

NASDAQ: NIVF · Real-Time Price · USD
1.85
-0.07 (-3.65%)
At close: Aug 15, 2025, 2:49 PM

NewGenIvf Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-474.1K 130.19K 500.65K -138.53K
Depreciation & Amortization
206.26K 229.71K 303.94K 342.54K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-8.89M -2.58M 528.89K 734.85K
Other Non-Cash Items
247.54K -60.51K -2.25M 497.6K
Deferred Income Tax
-486.71K n/a 208.14K n/a
Change in Working Capital
-7.76M -2.09M 710.35K 731.39K
Operating Cash Flow
-8.26M -1.79M -527.12K 1.43M
Capital Expenditures
-53.04K -69.85K -94.45K -16.57K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a -780K -69.69M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 780K 94.45K n/a
Investing Cash Flow
-53.05K -69.85K -69.69M -16.57K
Debt Repayment
8.58M -9.32K 108.73K 495.6K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
98.64K 1.72M -1.71M -2.04M
Financial Cash Flow
8.68M 1.91M 70.27M -1.54M
Net Cash Flow
403.64K -615 54.72K -77.43K
Free Cash Flow
-8.32M -1.84M -621.58K 1.42M